Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Bane
L M Shurkus

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
AORN Journal|April 30, 1998
Adhesion reduction as a new treatment innovationC L Bane, C Jennings
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531)V Roy, B R LaPlant, G G Gross, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
AORN Journal|April 30, 1998
Adhesion reduction as a new treatment innovationC L Bane, C Jennings
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531)V Roy, B R LaPlant, G G Gross, et al.
Pageof 1